Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
HepGene Medical AB
AB
Active
Org 5590556592
Varpetvägen 9, 437 91
Lindome
Medical specialists activities
·
NACE 8622
Est. 2016 · 10 years old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
HepGene Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 1M (-50% vs 2022)
1M
-50%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
1M
1M
1M
0M
0M
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 043
968
1 223
1 531
2 001
Staff expenses
−249
−64
−98
—
—
EBITDA
597
644
818
1 124
346
Depreciation & amort.
−147
−145
−89
−48
−48
EBIT
450
499
729
1 076
298
Net financials
90
60
39
21
—
Profit before tax
539
559
801
1 107
297
Tax
−113
−114
−167
−232
−65
Net profit
426
445
634
875
232
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 956
1 829
1 665
1 240
1 208
Equity
1 904
1 682
1 426
982
497
Long-term debt
—
—
—
0
0
Short-term debt
52
147
239
225
678
Total debt
52
147
239
225
678
Financial ratios
5-year trend
EBITDA margin
57,2 %
This company
15,8 %
Market median
This company
Market median
262% above market
2021
2025
Equity ratio
97,3 %
This company
38,2 %
Market median
This company
Market median
155% above market
2021
2025
Return on equity
22,4 %
This company
18,4 %
Market median
This company
Market median
22% above market
2021
2025
Net profit margin
40,8 %
This company
8,1 %
Market median
This company
Market median
404% above market
2021
2025
Asset turnover
0,53×
This company
1,12×
Market median
This company
Market median
53% below market
2021
2025
Debt / equity
0,03×
This company
0,62×
Market median
This company
Market median
95% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
View
PDF
More on HepGene Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
